Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04920981
Status:
COMPLETED
Last Update Posted:
2023-01-06
First Post:
2021-04-28
Brief Title:
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Organization:
Intergroupe Francophone de Cancerologie Thoracique
Organization Data
Organization:
Intergroupe Francophone de Cancerologie Thoracique
Class:
OTHER
Study ID:
IFCT-1905
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |
| GFPC | UNKNOWN |